Skip to content
All Podcasts – Lifestyle
Author:
Sunshine Biopharma Inc.
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
September 24, 2026
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
September 16, 2026
Galway Metals Continues to Demonstrate Broad Gold Mineralization at Southwest Deposit; 2.0 g/t Gold Over 68.0 Metres
August 24, 2026
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 7, 2026
Galway Metals Reports Broad Gold Intercepts from Southwest Deposit, Including 2.6 g/t Over 48.0 Metres
August 5, 2026
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 4, 2026
Health Canada Approves Sunshine Biopharma’s Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
July 28, 2026
Galway Metals Commences Preliminary Economic Assessment at Clarence Stream Gold Project
July 23, 2026
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026
1
2
3
Next Page
→